International Stem Cell (OTCMKTS:ISCO) Stock Crosses Above 200-Day Moving Average – Should You Sell?

International Stem Cell Corp. (OTCMKTS:ISCO)’s stock price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.15 and traded as high as $0.1827. International Stem Cell shares last traded at $0.14, with a volume of 3,732 shares.

International Stem Cell Stock Performance

The company has a market capitalization of $1.12 million, a P/E ratio of -2.33 and a beta of 0.05. The stock has a fifty day moving average of $0.15 and a 200 day moving average of $0.15.

International Stem Cell (OTCMKTS:ISCO) last issued its quarterly earnings results on Monday, March 30th. The biotechnology company reported ($0.04) EPS for the quarter. The business had revenue of $2.15 million during the quarter.

About International Stem Cell

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.